References
- Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, et al. Randomised double blind comparison of chi-meric monoclonal antibody to tumor necrosis factor a (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344: 1105— 10.
- Maini RN, Elliott MJ, Brennan FM, Williams RO, Chu CQ, Paleolog E, et al. Monoclonal anti-TNFa antibody as a probe of pathogenesis and therapy of rheumatoid arthritis. Immunol Rev 1995;144:195 — 223.
- Paulus HE, Egger MJ, Ward JR, Williams Hj. The Cooperative Systematic Studies of Rheumatic Disease Group. Analysis of improved in individual rheumatoid arthritis patients treated with disease modifying anti-rheumatic drugs, based on the finding in patients treated with placebo. Arthritis Rheum 1990;33:477 —84.
- Numata Y, Matsuura Y, Onishi S, Yamamoto Y, Ohno F, Tagoh H, et al. Interleukin-6 positive follicular hyperplasia in lymph node of a patient with rheumatoid arthritis. Am J Hematol 1991;36:282 —4.
- Kishimoto T. Interleukin-6 and its receptor in autoimmunity. J Autoimmun 1992;5 Suppl A:123 — 32.
- Pisa EK, Pisa P, Hausson M, Wigzell H. OKT-3 induced cyto-kine mRNA expression in human peripheral blood mononuc-lear cells measured by polymerase chain reaction. Scand J Immunol 1992;36:745 —9.